Boston Common Asset Management’s Organon & Co OGN Stock Holding History

Boston Common Asset Management’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-259,916	Closed	-$5.41M	–	307
2023 Q2	$5.41M	Sell	259,916 -10,539	-4%	-$229K	0.12%	196
2023 Q1	$6.36M	Sell	270,455 -2,948	-1%	-$79.2K	0.13%	188
2022 Q4	$7.64M	Buy	273,403 +16,797	+7%	+$429K	0.37%	91
2022 Q3	$6M	Sell	256,606 -124,614	-33%	-$3.76M	0.31%	96
2022 Q2	$12.9M	Buy	381,220 +1,498	+0.4%	+$52.5K	0.64%	57
2022 Q1	$13.3M	Buy	379,722 +63,317	+20%	+$2.17M	0.57%	68
2021 Q4	$9.63M	Buy	316,405 +10,284	+3%	+$335K	0.39%	83
2021 Q3	$10M	Buy	306,121 +87,367	+40%	+$2.8M	0.43%	78
2021 Q2	$6.62M	Buy	+218,754	New	+$7.2M	0.28%	93

Other funds holding OGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Boston Common Asset Management's OGN Position: Q3 2023 in Review

Boston Common Asset Management sold out of Organon & Co (OGN) in Q3 2023, closing a stake of 259,916 shares — an estimated $5.41M sold.

Boston Common Asset Management first reported a position in OGN in Q2 2021 and held it in 9 quarters. The position peaked at $13.3M in Q1 2022. 730 funds tracked by Wall St. Rank hold OGN as of Q3 2023.

Boston Common Asset Management reported no remaining Organon & Co position as of Q3 2023 after selling out during the quarter.
Boston Common Asset Management sold 259,916 Organon & Co shares in Q3 2023, an estimated $5.41M.
Boston Common Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 9 quarters.
Boston Common Asset Management's Organon & Co position peaked at $13.3M in Q1 2022.
730 funds tracked by Wall St. Rank held Organon & Co as of Q3 2023.

Based on Boston Common Asset Management's 13F filing for Q3 2023, filed 11 Oct 2023.